- Home
- IMAX vs CLDX Comparison
IMAX vs CLDX Comparison
Compare IMAX & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMAX | CLDX |
|---|---|---|
| Founded | 1967 | N/A |
| Country | Canada | United States |
| Employees | N/A | 198 |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 1997 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IMAX | CLDX |
|---|---|---|
| Price | $45.29 | $33.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $44.50 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 877.0K | 855.2K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $410,212,000.00 | $12,743,000.00 |
| Revenue This Year | $9.79 | $111.39 |
| Revenue Next Year | $7.51 | $235.85 |
| P/E Ratio | $642.43 | ★ N/A |
| Revenue Growth | 16.47 | ★ 87.78 |
| 52 Week Low | $24.20 | $19.52 |
| 52 Week High | $45.16 | $35.83 |
Technical Indicators
Market Signals| Indicator | IMAX | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 74.53 | 61.27 |
| Support Level | $33.57 | $28.51 |
| Resistance Level | N/A | $35.10 |
| Average True Range (ATR) | 1.37 | 1.15 |
| MACD | 0.33 | 0.44 |
| Stochastic Oscillator | 95.03 | 87.15 |
Price Performance
Historical ComparisonAbout IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.